InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,050.40
(
1.19%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
76.75
(
0.56%
)
Bitcoin
58,228.78
(
1.57%
)
Post# of 105534
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Starlost

Send PM Follow Ignore
Followers 239
Posts 33981
Boards Moderated 0
Alias Born 11/15/2009

Starlost

Re: None

Friday, 12/10/2010 8:37:56 AM

Friday, December 10, 2010 8:37:56 AM

Post# of 105534

The acquisition, when completed, means that Cord Blood America will control over 100,000 customers internationally, and expects its combined revenues to be in the $14M range annually if all businesses continue the same sales rate.

When you think about it, that's really small numbers-wise. Peanuts. I don't see the company value increasing much over the next few years. Really, storing cord blood is not a money maker. Probably was the wrong business to get into. That's why Cryocell sold.

70k since 2001 for Cyro-cell Mexico is not very impressive at all.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up